President and CEOOfficers of the CorporationBoard of TrusteesLeadership CouncilHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Adult ClinicPediatricsEye CareBillingInfo for Healthcare ProfessionalsDiabetes Information & Resources
Clinical Research50-Year Medalist Study
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternational
Give NowGet InvolvedEventsTributes & Special OccasionsCorporate & Foundation EngagementLegacy GivingWays to GivePhilanthropy TeamPublications

Professional Education

Joslin Diabetes Center is a leader in continuing education for healthcare professionals. Joslin's CME and CE activities promote the highest standards of care, drawing on up-to-date medical literature as well as cutting-edge research conducted at Joslin to provide current, relevant, and evidence-based findings from Joslin faculty and other experts. Our mission is to help providers offer their patients optimal management of diabetes and its related conditions, improved health outcomes, and enhanced quality of life.


Upcoming Live Activities

Join us for the series Insulin Replacement Therapy 2019: Evolving Treatments and their Clinical Implications

Presented by Joslin Diabetes Center in Joint Providership with PlatformQ Health Education, LLC. All sessions will be held as video webinars online. We will post the link to register for these activities shortly.

Live: June 27, 2019
Available On Demand through December 27, 2019

Thursday, June 27, 2019, from 11:00 AM ET – 2:00 PM ET
·       11:00 AM ET– 12:00 PM ET: Insulin Options for Diabetes: Update on their Evolution
·       12:00 PM ET– 1:00 PM ET: Insulin Therapy for Type 2 Diabetes: Current Clinical Perspectives
·       1:00 PM ET– 2:00 PM ET: Designing Insulin Replacement Program Workshop:  Individualizing and Optimizing Therapy

ACKNOWLEDGEMENT
This activity is supported by educational grants from Lilly, Novo Nordisk Inc., and Medtronic. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Session 1: Insulin Options for Diabetes: Update on their Evolution
11:00 am ET


Learning Objectives:
Discuss recent data on newer basal and prandial insulins, as well as insulin technology, and its implication on the design and implementation of insulin replacement therapies
Recognize the indications for initiation and/or advancement of, insulin replacement therapy for people with type 2 diabetes

 

Featured Speakers:

Richard S. Beaser, MD
Associate Professor of Medicine
Harvard Medical School
Senior Physician; Medical Director, Continuing Medical Education
Joslin Diabetes Center

 

Alissa R. Segal, PharmD, CDE, CDTC, FCCP
Professor of Pharmacy Practice
MCPHS University
Clincial Pharmacist
Joslin Diabetes Center

 

Watch top experts via streaming video, get the latest medical science, and earn AMA PRA Category 1 Credits™

Session 2: Insulin Therapy for Type 2 Diabetes: Current Clinical Perspectives
12:00pm ET


Learning Objectives:
Recognize the indications for initiation and/or advancement of, insulin replacement therapy for people with type 2 diabetes
Discuss the indications for therapeutic options beyond basal insulin only for people with type 2 diabetes, including combination with GLP-1 RAs, 1-3 premeal injections, or premixed formulations

Describe methods to design and advance basal/bolus multiple-injection insulin replacement therapies

Featured Speakers:

Richard S. Beaser, MD
Associate Professor of Medicine
Harvard Medical School
Senior Physician; Medical Director, Continuing Medical Education
Joslin Diabetes Center

Martin J. Abrahamson, MD, FACP
Associate Professor of Medicine
Harvard Medical School
Co-Director, Division of Continuing Medical Education, Department of Medicine
Beth Israel Deaconess Medical Center

Watch top experts via streaming video, get the latest medical science, and earn AMA PRA Category 1 Credits™

 

Session 3: Designing Insulin Replacement Program Workshop: Individualizing and Optimizing Therapy
1:00pm Et

Learning Objectives:
Discuss the indications for therapeutic options beyond basal insulin only for people with type 2 diabetes, including combination with GLP-1 RAs, 1-3 premeal injections, or premixed formulations
Describe methods to design and advance basal/bolus multiple injection insulin replacement therapies
Identify when the use of newer devices to monitor glycemia and deliver insulin may be indicated, and develop plan to oversee and coordinate their use with specialty care providers

Featured Speakers:

Richard S. Beaser, MD
Associate Professor of Medicine
Harvard Medical School
Senior Physician; Medical Director, Continuing Medical Education
Joslin Diabetes Center

Martin J. Abrahamson, MD, FACP
Associate Professor of Medicine
Harvard Medical School
Co-Director, Division of Continuing Medical Education, Department of Medicine
Beth Israel Deaconess Medical Center

Alissa R. Segal, PharmD, CDE, CDTC, FCCP
Professor of Pharmacy Practice
MCPHS University
Clincial Pharmacist
Joslin Diabetes Center

Watch top experts via streaming video, get the latest medical science, and earn AMA PRA Category 1 Credits™

 

Proven Success with Educational Outcomes

 

Joslin Diabetes Center has been at the forefront of measuring educational outcomes for our activities, based on the levels defined by Moore et al.1 We have been involved in several specific projects that measure the impact of our educational activities on clinician performance measures (Level 5) and patient outcomes measures (Level 6). Please click here to read about one of these initiatives entitled Targeting Type 2 Diabetes: Achieving Glycemic and Cardiometabolic Goals. This initiative was supported by educational grants from GlaxoSmithKline LLC and Merck Sharpe and Dohme Corp.

1 Moore DE Jr, Green JS, Gallis HA. Achieving desired results and improved outcomes: integrating planning and assessment throughout learning activities. J Contin Educ Health Prof. 2009;29(1):1-15.


 

Joslin at World Congress for CPD 2016

Joslin recently presented a session and a poster based on the performance improvement grant entitled Comparison of Methods for Assessing Clinical Performance Improvement in Primary Care.

View the poster here

Joslin Clinical Guidelines

To assist physicians and other healthcare professionals in managing the care of their patients with diabetes, Joslin offers approved clinical guidelines on a variety of topics including Adult Diabetes, Pharmacological Management of Type 2 Diabetes, and Continuous Glucose Monitors.

ACCME Awards Joslin CME Accreditation with Commendation